Liquidia (LQDA) Cash from Operations (2020 - 2026)
Liquidia's (LQDA) quarterly Cash from Operations came in at 52990000.0 in Q1 2026, up 272.72% year-on-year from 14216953.6 in Q1 2025, and up 19.77% quarter-over-quarter from 44244000.0 in Q4 2025.
Liquidia (LQDA) Cash from Operations (2020 - 2026) Analysis & Trends
Liquidia's Cash from Operations history runs 7 years deep, the most recent figure standing at 52990000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 272.72% year-over-year to 52990000.0 in Q1 2026; TTM through Mar 2026 was 47983000.0, a 148.35% increase from a year earlier, with the FY2025 full-year figure at 35686000.0, up 61.8% from the prior year.
- Cash from Operations rose to 52990000.0 in Q1 2026 per LQDA's latest filing, from 44244000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 52990000.0 in Q1 2026 and bottomed at 39481000.0 in Q2 2025.
- The 5-year median for Cash from Operations is 9782000.0 (2022), against an average of 8604117.65.
- Across the five-year window, Cash from Operations slumped 307.28% in 2024 and soared 312.58% in 2025, its largest moves.
- Year by year, Cash from Operations stood at 4603000.0 in 2022, then sank by 247.21% to 15982000.0 in 2023, then sank by 30.23% to 20813000.0 in 2024, then surged by 312.58% to 44244000.0 in 2025, then grew by 19.77% to 52990000.0 in 2026.
- Per Business Quant, the three latest LQDA Cash from Operations figures stand at 52990000.0 (Q1 2026), 44244000.0 (Q4 2025), and 9770000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 52.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.99 Mn |
| Mar 31, 2026 | 52.99 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Dec 31, 2025 | 44.24 Mn |
| Sep 30, 2025 | -9.77 Mn |
| Sep 30, 2025 | -9.77 Mn |
| Jun 30, 2025 | -39.48 Mn |
| Jun 30, 2025 | -39.48 Mn |
| Mar 31, 2025 | -30.68 Mn |
| Mar 31, 2025 | -30.68 Mn |
| Dec 31, 2024 | -20.81 Mn |
| Dec 31, 2024 | -20.81 Mn |
| Sep 30, 2024 | -25.08 Mn |
| Sep 30, 2024 | -25.08 Mn |
| Jun 30, 2024 | -22.66 Mn |
| Jun 30, 2024 | -22.66 Mn |
| Mar 31, 2024 | -24.87 Mn |
| Mar 31, 2024 | -24.87 Mn |
| Dec 31, 2023 | -15.98 Mn |
| Dec 31, 2023 | -15.98 Mn |